EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The NSP5, ORF6 and NSP13 of SARS‐CoV‐2 Cooperate to Modulate Inflammatory Cell Death Activation

Huan Wang, Mengdi Liang, Jing Zhang, Hua Tong, Fenfen Zhang, Ying Liu, Pui Wang, Mengmeng Chang, Fei Han, Siwen Liu, Yongping Lin, Wenjun Song und 5 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202503977 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Huan Wang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute of infectious diseases, Shenzhen Bay Laboratory, Shenzhen, Guangdong, 518132, China. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Viral Nonstructural Proteins, Viral Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Key Research and Development Plan of China, Shenzhen Medical Research Fund, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Programmed cell death is a pivotal mechanism of cell‐autonomous immune defense against viral infections. Recent studies indicate that both blocking and promoting cell death negatively affect coronavirus replication, implying that coronaviruses may fine‐tune cell death pathways to optimize their propagation. However, the mechanisms underlying this remain poorly understood. Here, it is verified that coronaviruses induce the formation of a Z‐DNA‐binding protein 1 (ZBP1)‐initiated cell death complex involving ZBP1, Z‐RNA, receptor‐interacting serine/threonine‐protein kinase 3 (RIPK3), and caspase‐8, thereby triggering apoptosis, pyroptosis, and necroptosis in human bronchial epithelial cells. To impede the activation of apoptosis and pyroptosis, NSP5 and ORF6 of SARS‐CoV‐2 concurrently inhibit caspase‐8 activity by targeting its large and small subunits, respectively. Additionally, NSP13, the viral helicase, interacts with RIPK3 to impair its binding to ZBP1, thus suppressing ZBP1‐initiated necroptosis. This inhibitory effect on cell death is likely conserved across β‐coronaviruses. Furthermore, co‐infection of influenza A virus and SARS‐CoV‐2 is demonstrated to exacerbate disease severity, although the mechanisms remain unclear. These findings suggest that β‐coronavirus‐induced inhibition of cell death enhances influenza A virus replication and worsens inflammation during their co‐infection, ultimately increasing mortality in mice. This research provides valuable insights into the regulation of coronavirus‐induced cell death, offering potential therapeutic strategies for combating highly pathogenic coronavirus infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19Viral Nonstructural ProteinsViral ProteinsHumansAnimalsMiceReceptor-Interacting Protein Serine-Threonine KinasesNecroptosisRNA-Binding ProteinsApoptosisPyroptosisCell DeathCaspase 8Epithelial CellsInflammationVirus Replication

Stichwörter der Autor:innen

NSP13PANoptosisRIPK3SARS‐CoV‐2ZBP1caspase‐8necroptosis

Substanzen

Receptor-Interacting Protein Serine-Threonine KinasesRNA-Binding ProteinsZBP1 protein, humanCaspase 8RIPK3 protein, humanViral Nonstructural ProteinsViral Proteins

Autor:innen und Institutionen

  • Institute of infectious diseases, Shenzhen Bay Laboratory, Shenzhen, Guangdong, 518132, China.
  • Guangdong Provincial Key Laboratory of Infection Immunity and Inflammation, Shenzhen, Guangdong, 518060, China.
  • Key Laboratory for Experimental Teratology of Ministry of Education and advanced Medical Research Institute, Meili Lake Translational Research Park, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.
  • Department of Microbiology and State Key Laboratory for Emerging Infectious Diseases, the University of Hong Kong, Hong Kong, 999077, China.
  • Department of Preventive Veterinary Medicine, Guangxi University, Nan Ning, 530004, China.
  • Department of Laboratory Medicine, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510030, China.

ORCID-Profile: Min Zheng

Förderung

  • The National Key Research and Development Plan of China
  • Shenzhen Medical Research Fund
  • National Natural Science Foundation of China
  • Shenzhen Bay Laboratory

Zitieren

APA

Wang, H., Liang, M., Zhang, J., Tong, H., Zhang, F., Liu, Y., Wang, P., Chang, M., Han, F., Liu, S., Lin, Y., Song, W., Karki, R., Wang, P., Chen, H., Liu, Y., & Zheng, M. (2025). The NSP5, ORF6 and NSP13 of SARS‐CoV‐2 Cooperate to Modulate Inflammatory Cell Death Activation. Advanced Science. https://doi.org/10.1002/advs.202503977

Vancouver

Wang H, Liang M, Zhang J, Tong H, Zhang F, Liu Y, et al. The NSP5, ORF6 and NSP13 of SARS‐CoV‐2 Cooperate to Modulate Inflammatory Cell Death Activation. Advanced Science. 2025. doi:10.1002/advs.202503977

BibTeX
@article{Wang2025,
  author = {Wang, Huan and Liang, Mengdi and Zhang, Jing and Tong, Hua and Zhang, Fenfen and Liu, Ying and Wang, Pui and Chang, Mengmeng and Han, Fei and Liu, Siwen and Lin, Yongping and Song, Wenjun and Karki, Rajendra and Wang, Peihui and Chen, Honglin and Liu, Yang and Zheng, Min},
  title = {The NSP5, ORF6 and NSP13 of SARS‐CoV‐2 Cooperate to Modulate Inflammatory Cell Death Activation},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202503977}
}
Kostenlos starten →